Type 2 inflammation in chronic obstructive pulmonary disease: A promising treatable trait and practice recommendations.
Chen Y, Yang T, Zhang J, Chen X, Chen X, Cheng Z, Li Y, Fan X, Han W, He Z, Ma D, Meng Y, Yan J, Yin Y, Zeng H, Zhou Q, Zhou X, Cai H, Cui Y, Ma Y, Wen F, Sun Y, Sun D, Liu X, Zheng J, Wang W, Zheng Z, Yan X, Cai S, Cao J, Song Y, Zhao J, Zhou Y, Zhu H, Li M, Guo Y, Ma Q, Liang Z, Zhao L, Chen Y, Wang J, Wang F, Yang Y, Yang H, Kang J, Chen R; Assembly of Chronic Obstructive Pulmonary Disease (COPD) of Chinese Thoracic Society (CTS); COPD Working Group of Chinese Association of Chest Physician (CACP) of the Chinese Medical Doctor Association; Evidence-Based Medicine Group of the Clinical Epidemiology Branch of the Chinese Medical Association; Respiratory Disease Control Committee of the Chinese Preventive Medicine Association; Precision Medicine Group of the Respiratory Disease Committee of the Cross-Strait Medical and Health Exchange Association.
Chen Y, et al. Among authors: cui y.
Chin Med J Pulm Crit Care Med. 2025 Dec 13;3(4):225-245. doi: 10.1016/j.pccm.2025.11.004. eCollection 2025 Dec.
Chin Med J Pulm Crit Care Med. 2025.
PMID: 41551016
Free PMC article.